News

First Etravirine Active Pharmaceutical Ingredient (API) prequalified

Etravirine (WHOAPI-280) manufactured by Mylan Laboratories Ltd has been prequalified by the WHO Prequalification Team: medicines under its API prequalification procedure. FPPs containing etravirine are used in the therapeutic area of HIV/AIDS.

  • WHOAPI-280 - Etravirine - Mylan Laboratories Ltd - INDIA 

    • This represents the first etravirine API to be prequalified.

 

Good-quality APIs are vital to the production of good-quality medicines.  WHO prequalification of APIs facilitates production of quality medicines by identifying such APIs for use by manufacturers of finished pharmaceutical products (FPPs).

API prequalification consists of a comprehensive evaluation procedure that has two components: assessment of the API master file (APIMF) to verify compliance with WHO norms and standards, and evaluation of the sites of API manufacture to verify compliance with WHO Good Manufacturing Practice requirements.